Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 56 | 2023 | 2026 | 3.380 |
Why?
|
Infectious Disease Transmission, Vertical | 29 | 2021 | 1320 | 2.030 |
Why?
|
HIV Infections | 45 | 2021 | 16715 | 1.170 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2015 | 1872 | 0.960 |
Why?
|
HIV Protease Inhibitors | 6 | 2010 | 430 | 0.900 |
Why?
|
Anti-HIV Agents | 16 | 2021 | 4255 | 0.870 |
Why?
|
Cesarean Section | 10 | 2018 | 1365 | 0.860 |
Why?
|
HIV-1 | 24 | 2016 | 6939 | 0.850 |
Why?
|
Cesarean Section, Repeat | 1 | 2018 | 29 | 0.640 |
Why?
|
Viral Load | 7 | 2021 | 3300 | 0.630 |
Why?
|
Pregnancy | 77 | 2023 | 29144 | 0.610 |
Why?
|
Delivery, Obstetric | 9 | 2018 | 906 | 0.470 |
Why?
|
Pregnancy Outcome | 9 | 2017 | 2795 | 0.440 |
Why?
|
Nevirapine | 3 | 2010 | 267 | 0.430 |
Why?
|
Prenatal Care | 6 | 2019 | 1092 | 0.390 |
Why?
|
Bacteremia | 5 | 2019 | 963 | 0.380 |
Why?
|
Peripartum Period | 4 | 2019 | 133 | 0.360 |
Why?
|
RNA, Viral | 8 | 2015 | 2901 | 0.340 |
Why?
|
Puerperal Disorders | 5 | 2019 | 275 | 0.340 |
Why?
|
Nelfinavir | 2 | 2010 | 68 | 0.330 |
Why?
|
Hepatitis B, Chronic | 3 | 2019 | 393 | 0.320 |
Why?
|
Chemoprevention | 1 | 2010 | 319 | 0.310 |
Why?
|
Lamivudine | 2 | 2010 | 342 | 0.300 |
Why?
|
Indinavir | 1 | 2006 | 74 | 0.290 |
Why?
|
Vagina | 8 | 2004 | 825 | 0.290 |
Why?
|
Therapeutic Human Experimentation | 1 | 2007 | 43 | 0.290 |
Why?
|
Drug Resistance, Viral | 2 | 2010 | 820 | 0.280 |
Why?
|
Ritonavir | 2 | 2023 | 322 | 0.270 |
Why?
|
Fever | 3 | 2019 | 1616 | 0.260 |
Why?
|
Antibiotic Prophylaxis | 1 | 2010 | 639 | 0.260 |
Why?
|
Zidovudine | 6 | 2010 | 620 | 0.260 |
Why?
|
Hepatitis, Viral, Human | 1 | 2005 | 138 | 0.260 |
Why?
|
Acyclovir | 1 | 2005 | 272 | 0.250 |
Why?
|
Obstetric Labor, Premature | 2 | 2004 | 279 | 0.250 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 615 | 0.240 |
Why?
|
Lactams | 1 | 2023 | 156 | 0.220 |
Why?
|
Puerperal Infection | 4 | 2017 | 46 | 0.220 |
Why?
|
Genitalia, Female | 2 | 2003 | 146 | 0.220 |
Why?
|
Herpes Simplex | 1 | 2005 | 470 | 0.210 |
Why?
|
Antiviral Agents | 2 | 2023 | 2987 | 0.210 |
Why?
|
Infant, Newborn | 27 | 2021 | 25628 | 0.210 |
Why?
|
Leucine | 1 | 2023 | 560 | 0.210 |
Why?
|
Proline | 1 | 2023 | 458 | 0.200 |
Why?
|
Female | 86 | 2023 | 380193 | 0.190 |
Why?
|
Obstetric Labor Complications | 2 | 2017 | 238 | 0.190 |
Why?
|
Pregnancy Trimester, Third | 4 | 2015 | 571 | 0.190 |
Why?
|
Premature Birth | 4 | 2021 | 1721 | 0.180 |
Why?
|
Multivariate Analysis | 9 | 2018 | 12244 | 0.180 |
Why?
|
Pregnancy in Diabetics | 2 | 2017 | 179 | 0.170 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 1996 | 140 | 0.170 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 30 | 0.170 |
Why?
|
Vaginosis, Bacterial | 3 | 2004 | 128 | 0.170 |
Why?
|
Nitriles | 1 | 2023 | 955 | 0.160 |
Why?
|
Labor, Obstetric | 2 | 2021 | 333 | 0.160 |
Why?
|
Research | 1 | 2007 | 1999 | 0.160 |
Why?
|
Uterine Diseases | 1 | 2019 | 135 | 0.150 |
Why?
|
Adult | 55 | 2019 | 214052 | 0.150 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 2004 | 2232 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 9 | 2010 | 2560 | 0.140 |
Why?
|
Streptococcus agalactiae | 2 | 2013 | 375 | 0.140 |
Why?
|
Cervix Uteri | 4 | 2004 | 590 | 0.140 |
Why?
|
Preconception Care | 1 | 2017 | 134 | 0.140 |
Why?
|
Cohort Studies | 23 | 2019 | 40559 | 0.130 |
Why?
|
Humans | 86 | 2023 | 744366 | 0.130 |
Why?
|
Patient Selection | 1 | 2007 | 4216 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2015 | 162 | 0.120 |
Why?
|
Postpartum Period | 4 | 2016 | 1086 | 0.120 |
Why?
|
Streptococcal Infections | 2 | 2013 | 638 | 0.120 |
Why?
|
Respiratory Distress Syndrome, Newborn | 2 | 2010 | 214 | 0.120 |
Why?
|
Accreditation | 1 | 2016 | 452 | 0.110 |
Why?
|
Infant, Premature | 7 | 2005 | 2045 | 0.110 |
Why?
|
Bacteria | 2 | 2004 | 2115 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2018 | 1184 | 0.110 |
Why?
|
Angiomatosis, Bacillary | 1 | 1992 | 4 | 0.110 |
Why?
|
Postnatal Care | 1 | 2014 | 236 | 0.110 |
Why?
|
Interleukin-1 | 3 | 2004 | 1263 | 0.100 |
Why?
|
Virus Shedding | 3 | 2003 | 108 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2006 | 657 | 0.100 |
Why?
|
Anti-Retroviral Agents | 3 | 2010 | 1714 | 0.100 |
Why?
|
Clinical Competence | 2 | 2018 | 4687 | 0.100 |
Why?
|
Pregnant Women | 2 | 2021 | 568 | 0.100 |
Why?
|
Parity | 1 | 2015 | 929 | 0.100 |
Why?
|
Risk Factors | 21 | 2017 | 72296 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1035 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2005 | 2861 | 0.100 |
Why?
|
Regression Analysis | 4 | 2010 | 6459 | 0.100 |
Why?
|
Gynecology | 1 | 2016 | 513 | 0.090 |
Why?
|
Azithromycin | 1 | 2011 | 196 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 870 | 0.090 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7182 | 0.090 |
Why?
|
Gestational Age | 5 | 2011 | 3493 | 0.090 |
Why?
|
Logistic Models | 8 | 2017 | 13409 | 0.090 |
Why?
|
Obstetrics | 1 | 2016 | 658 | 0.080 |
Why?
|
Contraceptives, Oral | 1 | 2011 | 564 | 0.080 |
Why?
|
Pregnancy Trimester, Second | 3 | 2007 | 732 | 0.080 |
Why?
|
Cefazolin | 2 | 1988 | 96 | 0.080 |
Why?
|
Medication Adherence | 2 | 2021 | 2063 | 0.080 |
Why?
|
Infant, Low Birth Weight | 4 | 2002 | 850 | 0.080 |
Why?
|
Decision Trees | 2 | 2019 | 506 | 0.080 |
Why?
|
United States | 10 | 2021 | 69872 | 0.080 |
Why?
|
Prospective Studies | 18 | 2016 | 53290 | 0.080 |
Why?
|
Surgical Wound Infection | 3 | 2010 | 1540 | 0.070 |
Why?
|
Massachusetts | 6 | 2018 | 8662 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2540 | 0.070 |
Why?
|
Herpes Genitalis | 1 | 2008 | 140 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2007 | 128 | 0.070 |
Why?
|
Drug Therapy, Combination | 4 | 2010 | 6489 | 0.070 |
Why?
|
Herpesvirus 2, Human | 1 | 2008 | 189 | 0.070 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2006 | 115 | 0.070 |
Why?
|
Moxalactam | 1 | 1985 | 10 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2017 | 1900 | 0.070 |
Why?
|
Insurance, Health | 1 | 2017 | 2494 | 0.060 |
Why?
|
Smoking | 4 | 2006 | 8987 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3020 | 0.060 |
Why?
|
DNA, Viral | 4 | 2006 | 2227 | 0.060 |
Why?
|
Odds Ratio | 5 | 2017 | 9849 | 0.060 |
Why?
|
Maternal-Fetal Exchange | 1 | 2006 | 456 | 0.060 |
Why?
|
Prevalence | 6 | 2019 | 15221 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4386 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4092 | 0.060 |
Why?
|
Pyrimidinones | 1 | 2006 | 370 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2007 | 317 | 0.060 |
Why?
|
Young Adult | 7 | 2019 | 56429 | 0.060 |
Why?
|
HIV | 2 | 2021 | 1604 | 0.060 |
Why?
|
Hysterectomy | 3 | 1988 | 927 | 0.060 |
Why?
|
Ampicillin | 2 | 2001 | 139 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3922 | 0.060 |
Why?
|
Health Education | 1 | 1990 | 1056 | 0.060 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.060 |
Why?
|
Sialoglycoproteins | 1 | 2004 | 318 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1997 | 4479 | 0.060 |
Why?
|
Liver Failure | 1 | 2005 | 241 | 0.060 |
Why?
|
HIV Seropositivity | 3 | 2004 | 971 | 0.060 |
Why?
|
Area Under Curve | 3 | 2015 | 1655 | 0.060 |
Why?
|
Time Factors | 6 | 2016 | 40075 | 0.060 |
Why?
|
Case-Control Studies | 8 | 2017 | 21748 | 0.050 |
Why?
|
Apgar Score | 1 | 2002 | 123 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3154 | 0.050 |
Why?
|
Simplexvirus | 1 | 2005 | 803 | 0.050 |
Why?
|
Adolescent | 9 | 2015 | 85779 | 0.050 |
Why?
|
Body Weight | 1 | 2011 | 4671 | 0.050 |
Why?
|
Pelvic Inflammatory Disease | 2 | 1994 | 94 | 0.050 |
Why?
|
Liver | 2 | 2006 | 7475 | 0.050 |
Why?
|
Papillomaviridae | 1 | 2006 | 1119 | 0.050 |
Why?
|
Fetal Death | 1 | 2002 | 448 | 0.050 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 77460 | 0.040 |
Why?
|
Infant | 6 | 2021 | 35134 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2007 | 1095 | 0.040 |
Why?
|
Endometritis | 3 | 1996 | 48 | 0.040 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 26 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10637 | 0.040 |
Why?
|
Gene Products, env | 1 | 2000 | 263 | 0.040 |
Why?
|
HIV Wasting Syndrome | 1 | 1998 | 97 | 0.040 |
Why?
|
Meconium Aspiration Syndrome | 1 | 1997 | 29 | 0.040 |
Why?
|
Infection Control | 1 | 1985 | 965 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1607 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2005 | 6366 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1178 | 0.040 |
Why?
|
Mass Screening | 2 | 1990 | 5253 | 0.040 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 1997 | 25 | 0.040 |
Why?
|
Premedication | 3 | 1988 | 258 | 0.040 |
Why?
|
Age Factors | 4 | 2019 | 18373 | 0.030 |
Why?
|
Risk Assessment | 5 | 2010 | 23336 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5791 | 0.030 |
Why?
|
Semen | 1 | 1998 | 316 | 0.030 |
Why?
|
New York | 1 | 1998 | 886 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2011 | 1572 | 0.030 |
Why?
|
Risk | 3 | 2006 | 9688 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 305 | 0.030 |
Why?
|
Reproductive History | 1 | 1996 | 209 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2865 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1997 | 793 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2016 | 211 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 403 | 0.030 |
Why?
|
Women's Health | 1 | 2004 | 2034 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2006 | 1587 | 0.030 |
Why?
|
Maternal Age | 1 | 2017 | 802 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14723 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 570 | 0.030 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 1997 | 306 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4328 | 0.030 |
Why?
|
Candida albicans | 1 | 1997 | 394 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2018 | 3531 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6755 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 1998 | 1041 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3771 | 0.030 |
Why?
|
Vaginal Smears | 3 | 2004 | 511 | 0.030 |
Why?
|
Homosexuality | 1 | 1993 | 262 | 0.030 |
Why?
|
Hepatitis B | 1 | 2018 | 695 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7730 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 3338 | 0.030 |
Why?
|
Pregnancy, Tubal | 1 | 1992 | 16 | 0.030 |
Why?
|
Cefoxitin | 2 | 1994 | 36 | 0.030 |
Why?
|
HIV Antibodies | 2 | 1998 | 1322 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1996 | 525 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12961 | 0.020 |
Why?
|
Counseling | 2 | 1990 | 1523 | 0.020 |
Why?
|
Voluntary Programs | 1 | 1990 | 42 | 0.020 |
Why?
|
Birth Weight | 1 | 1999 | 2069 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7282 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1995 | 952 | 0.020 |
Why?
|
Chlamydia trachomatis | 1 | 1992 | 246 | 0.020 |
Why?
|
Thrombophlebitis | 2 | 1996 | 309 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1210 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1425 | 0.020 |
Why?
|
Cefamandole | 1 | 1988 | 9 | 0.020 |
Why?
|
Gastroenterology | 1 | 2014 | 538 | 0.020 |
Why?
|
Chlamydia Infections | 1 | 1992 | 365 | 0.020 |
Why?
|
Tablets | 1 | 2008 | 145 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5388 | 0.020 |
Why?
|
Hysterectomy, Vaginal | 1 | 1988 | 37 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5101 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2016 | 1181 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3528 | 0.020 |
Why?
|
Testosterone | 1 | 1998 | 2419 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 63107 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2488 | 0.020 |
Why?
|
Probability | 2 | 2004 | 2506 | 0.020 |
Why?
|
Neutrophils | 2 | 2015 | 3721 | 0.020 |
Why?
|
Incidence | 3 | 2019 | 20952 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 1988 | 182 | 0.020 |
Why?
|
Mezlocillin | 1 | 1986 | 3 | 0.020 |
Why?
|
Actinomycosis | 1 | 1986 | 21 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1999 | 2020 | 0.020 |
Why?
|
Mutation | 2 | 2010 | 29786 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10183 | 0.020 |
Why?
|
Models, Biological | 1 | 2003 | 9584 | 0.020 |
Why?
|
Pneumonia | 1 | 1997 | 2133 | 0.020 |
Why?
|
Perinatal Care | 1 | 2008 | 227 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2408 | 0.020 |
Why?
|
Male | 6 | 2016 | 350115 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6542 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3873 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 254 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39052 | 0.010 |
Why?
|
Random Allocation | 2 | 1986 | 2428 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2760 | 0.010 |
Why?
|
Gravidity | 1 | 2003 | 51 | 0.010 |
Why?
|
Enterobacteriaceae Infections | 1 | 1985 | 187 | 0.010 |
Why?
|
Pregnancy Trimesters | 1 | 2004 | 192 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
Uterus | 1 | 1988 | 711 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 2007 | 258 | 0.010 |
Why?
|
Uterine Hemorrhage | 2 | 1998 | 255 | 0.010 |
Why?
|
Guanine | 1 | 2004 | 274 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2004 | 297 | 0.010 |
Why?
|
Cytokines | 1 | 1998 | 7323 | 0.010 |
Why?
|
Curriculum | 1 | 2016 | 3605 | 0.010 |
Why?
|
Poisson Distribution | 1 | 2004 | 513 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.010 |
Why?
|
Quality of Life | 2 | 2021 | 12802 | 0.010 |
Why?
|
Genotype | 2 | 2010 | 12952 | 0.010 |
Why?
|
Urinary Tract Infections | 2 | 1986 | 788 | 0.010 |
Why?
|
Tuberculosis | 1 | 1995 | 1912 | 0.010 |
Why?
|
Ampicillin Resistance | 1 | 2001 | 11 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1987 | 792 | 0.010 |
Why?
|
Depression | 1 | 2021 | 7759 | 0.010 |
Why?
|
Introns | 1 | 2004 | 992 | 0.010 |
Why?
|
Reference Values | 2 | 2001 | 4982 | 0.010 |
Why?
|
Catheterization | 1 | 2007 | 1470 | 0.010 |
Why?
|
Extraction, Obstetrical | 1 | 2001 | 26 | 0.010 |
Why?
|
Disease Progression | 2 | 2009 | 13286 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 593 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 25039 | 0.010 |
Why?
|
Parturition | 1 | 2005 | 441 | 0.010 |
Why?
|
Survival Analysis | 2 | 2004 | 10252 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 2000 | 47 | 0.010 |
Why?
|
Fetal Blood | 1 | 2006 | 1318 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.010 |
Why?
|
Adenine | 1 | 2004 | 936 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1998 | 112 | 0.010 |
Why?
|
Ovary | 1 | 1983 | 981 | 0.010 |
Why?
|
Proviruses | 1 | 2000 | 318 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2887 | 0.010 |
Why?
|
Oropharynx | 1 | 1998 | 127 | 0.010 |
Why?
|
Primary Health Care | 1 | 2014 | 4557 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1998 | 158 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1986 | 1401 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2684 | 0.010 |
Why?
|
Herpesviridae Infections | 1 | 1998 | 277 | 0.010 |
Why?
|
Urine | 1 | 1998 | 370 | 0.010 |
Why?
|
Menstruation | 1 | 1998 | 302 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1998 | 711 | 0.010 |
Why?
|
Infant, Small for Gestational Age | 1 | 1999 | 440 | 0.010 |
Why?
|
Mothers | 1 | 2007 | 2165 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 2001 | 582 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1987 | 2647 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2001 | 1877 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1768 | 0.010 |
Why?
|
Infant, Very Low Birth Weight | 1 | 1997 | 407 | 0.010 |
Why?
|
Sulbactam | 1 | 1994 | 26 | 0.010 |
Why?
|
Double-Blind Method | 2 | 1986 | 12025 | 0.010 |
Why?
|
Age of Onset | 1 | 2001 | 3270 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1995 | 214 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1998 | 733 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1998 | 1588 | 0.010 |
Why?
|
Clindamycin | 1 | 1994 | 139 | 0.010 |
Why?
|
Placebos | 1 | 1998 | 1676 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 11726 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2004 | 5974 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10388 | 0.010 |
Why?
|
Gentamicins | 1 | 1994 | 255 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 1990 | 5135 | 0.010 |
Why?
|
Doxycycline | 1 | 1994 | 326 | 0.010 |
Why?
|
Middle Aged | 5 | 2011 | 213390 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1992 | 301 | 0.010 |
Why?
|
Physical Examination | 1 | 1996 | 1237 | 0.010 |
Why?
|
Nutritional Status | 1 | 1998 | 1609 | 0.010 |
Why?
|
Leukocytes | 1 | 1998 | 2045 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1985 | 7914 | 0.010 |
Why?
|
Sexual Partners | 1 | 1993 | 729 | 0.010 |
Why?
|
Body Composition | 1 | 1998 | 2402 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12356 | 0.010 |
Why?
|
Weight Gain | 1 | 1998 | 2293 | 0.000 |
Why?
|
Risk-Taking | 1 | 1993 | 986 | 0.000 |
Why?
|
Chorioamnionitis | 1 | 1989 | 155 | 0.000 |
Why?
|
Length of Stay | 1 | 2001 | 6311 | 0.000 |
Why?
|
Labor Stage, Second | 1 | 1987 | 31 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2003 | 13991 | 0.000 |
Why?
|
Myometrium | 1 | 1988 | 181 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1988 | 552 | 0.000 |
Why?
|
Labor, Induced | 1 | 1987 | 146 | 0.000 |
Why?
|
Barium Sulfate | 1 | 1986 | 180 | 0.000 |
Why?
|
Enema | 1 | 1986 | 141 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1677 | 0.000 |
Why?
|
Pilot Projects | 1 | 1998 | 8319 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2004 | 15520 | 0.000 |
Why?
|
Endometrium | 1 | 1988 | 424 | 0.000 |
Why?
|
Medical Records | 1 | 1990 | 1413 | 0.000 |
Why?
|
Infant Mortality | 1 | 1989 | 754 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15297 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1988 | 2327 | 0.000 |
Why?
|
Confidentiality | 1 | 1987 | 612 | 0.000 |
Why?
|
Sepsis | 1 | 1996 | 2593 | 0.000 |
Why?
|
Hospitalization | 1 | 2001 | 10259 | 0.000 |
Why?
|
Informed Consent | 1 | 1987 | 995 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1990 | 2055 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1983 | 20130 | 0.000 |
Why?
|
Aged | 1 | 1985 | 163288 | 0.000 |
Why?
|